MANUSCRIPT SUBMISSION

(ALL SUBMISSIONS BECOME THE PROPERTY OF DRUG DEVELOPMENT & DELIVERY)

Drug Development & Delivery welcomes objective, well-balanced manuscripts that describe emerging or steadfast drug development techniques and information and their practical application to professionals in industry, academia, and government. Manuscripts should be forwarded with the understanding that they have not been published previously and are not under consideration for publication elsewhere.

Authors are responsible for all statements made in their work. All manuscripts are subject to peer review and copyediting. Authors of accepted papers will have an opportunity to review galleys. Upon acceptance, copyright of the manuscript is transferred to Drug Development & Delivery. If illustrations or other material in a manuscript have been published previously, the author is responsible for obtaining permission to republish. Rejected manuscripts are returned upon request. Drug Development & Delivery is not responsible for loss of materials.

MANUSCRIPT PREPARATION

(1,800 minimum/2,000 words maximum)

For papers with multiple authors, designate a single author to handle correspondence. Include this author’s full mailing address, telephone number, and e-mail address in the cover letter that accompanies the manuscript. The following should appear on separate pages with appropriate headings:

• Title page (with each author’s name, affiliation, and title)
• Abstract or introduction
• Organized body of article (with headings where appropriate)
• References (follow AMA manual of style)
• Author(s) bio(s), including current title and place of employment, academic and association affiliations/honors, schooling and related degrees, and other specifically related accomplishments, achievements (60-word maximum for each author)
• Captions for illustrations, charts, tables, photos, etc.

Please send color digital photo of author(s).

Visuals – Electronic/digital (JPEG) photos, visuals, illustrations, charts, graphs, etc. (along with printed versions) should be sent via e-mail.

SUBMISSION GUIDELINES FOR TECHNICAL ARTICLES

(For the magazine, which is also posted in HTML and PDF format on the website)

• All text should be in Microsoft Word (body text should not exceed 2500 words, minimum 2000 words, headings & subheadings where appropriate)
• Any images, figures and logos must be submitted in high resolution
• Bios and headshots of all authors are required (see examples in magazine)
• References should be formatted just as you see in our magazine

SUBMISSION GUIDELINES FOR WHITE PAPERS

(Website only)

• All text should be in Microsoft Word (body text should not exceed 1800 words, minimum 1500 words, headings & subheadings where appropriate)
• All visuals should be sent as 2 inches high x 3 inch wide JPEGs at 300 dpi (visuals should not exceed 5)
• Bios and headshots of all authors are required (see examples in magazine)
• References should be formatted just as you see in our magazine
• Company logo required

DRUG DEVELOPMENT EXECUTIVE INTERVIEW

Drug Development Executive interview is a multimedia program that reaches the industry through a combination of online and print marketing to subscribers and visitors to www.drug-dev.com.

The article is published as a 2-3 page interview in Drug Development & Delivery magazine with a company executive highlighting their organization’s goals, objectives and technologies.

Once published the Drug Development Executive interview is sent to all online subscribers in an email announcing the issue highlights including the interview.

It is also converted to HTML and posted in the special dedicated Drug Development Executive section at www.drug-dev.com.

Executive interview submission guidelines: Executive Interview (about 1800 words, hi-res company logo, and executive headshot). Draft 6 to 7 questions that best suit your initiatives for what message you most want to get out to our readers. Our readers expect the interviews to cover the company, and what it is doing in the drug development industry that makes them unique.

INSTRUCTIONS FOR SUBMITTING YOUR COMPANY PROFILE

• Submit a 400-word profile of your company, including core technologies, products, and/or services (please include company address, website, phone, fax, and contact information at top).
• Submit a company logo and one visual of your product, technology, or company facility.
• When e-mailing your information, please submit text in Microsoft Word and any visuals in JPEG or TIFF (300 dpi) format.

Cindy H. Dubin
Managing Editor
E-mail: cdubin@drug-dev.com